Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
letter
. 2005 Dec;64(12):1805–1807. doi: 10.1136/ard.2005.036715

Population based studies of biological antirheumatic drug use in southern Sweden: comparison with pharmaceutical sales

P Geborek, E Nitelius, S Noltorp, H Petri, L Jacobsson, L Larsson, T Saxne, I Leden
PMCID: PMC1755306  PMID: 16284356

Full Text

The Full Text of this article is available as a PDF (146.6 KB).

Figure 1.

Figure 1

Open in a new tab

 Total and drug related yearly biological drug costs (A) and number of patients treated with biological drugs related to the diagnosis (B) during 1999–2003 in Scania, derived from SSATG information.

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES